MARKET

ADRX

ADRX

ADARx Pharmaceuticals
NASDAQ
13.23
-0.06
-0.45%
After Hours: 13.23 0 0.00% 19:30 11/06 EST
OPEN
13.73
PREV CLOSE
13.29
HIGH
13.73
LOW
12.50
VOLUME
440.02K
TURNOVER
--
52 WEEK HIGH
23.21
52 WEEK LOW
12.50
MARKET CAP
1.41B
P/E (TTM)
-29.1795
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADRX last week (1026-1030)?
Weekly Report · 5d ago
Russell 2000 estimated to add 107 stocks in December rebalance - Stephens
Seeking Alpha · 10/29 19:12
Weekly Report: what happened at ADRX last week (1019-1023)?
Weekly Report · 10/26 10:35
TD Cowen Initiates Coverage On Adarx Pharmaceuticals with Buy Rating
Benzinga · 10/20 14:06
ADARx Pharmaceuticals Initiated at Overweight by JP Morgan
Dow Jones · 10/20 12:58
ADARx Pharmaceuticals Price Target Announced at $38.00/Share by JP Morgan
Dow Jones · 10/20 12:58
ADARx Pharmaceuticals Price Target Announced at $35.00/Share by UBS
Dow Jones · 10/20 12:36
This Restaurant Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 10/20 12:31
More
About ADRX
ADARx Pharmaceuticals, Inc. is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. The Company is focused on advancing and expanding its pipeline of highly potent, selective and durable siRNA therapeutic candidates, including three clinical-stage programs and two advanced preclinical programs. siRNA, or small interfering RNA, therapeutics represent a significant advancement in precision medicine by addressing diseases at the genetic level (mRNA or RNA) while avoiding permanent alterations to a patient’s genome (DNA). Its hepatic-targeted programs include Agazisiran, Onvuzosiran, and ADX-626. Its extrahepatic-targeted programs include ADX-077 and ADX-199. ADX-077 is designed to reduce body weight and fat while preserving lean mass. ADX-626, is in development for secondary stroke prevention with additional clinical potential for stroke prevention in atrial fibrillation.

Webull offers ADARx Pharmaceuticals, Inc. stock information, including NASDAQ: ADRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADRX stock methods without spending real money on the virtual paper trading platform.